SecBot SecBot
144 ·Filed Jun 5, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001950047-26-005723
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for additional Form 4 filings and any upcoming corporate events (earnings, pipeline updates) that could explain the selling. The stock's high analyst bullishness (94% buy ratings) contrasts with insider behavior, creating a potential divergence to watch.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$51.36
T+0 close · Jun 5, 2026 · via day close
Latest settled
+7.63%
T+60 · $55.28
Vs SPY
+4.58%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 8 $51.36entry
  2. T+1 · 5mo ago +0.53%α +0.82% · $51.63
  3. T+5 · 5mo ago +15.87%α +13.76% · $59.51
  4. T+20 · 4mo ago +21.32%α +19.69% · $62.31
  5. T+60 · 3mo ago +7.63%α +4.58% · $55.28

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on June 5, 2026, indicating intent to sell 22,491 shares of common stock valued at approximately $1.15 million. The filing also reveals a pattern of recent sales totaling over 160,000 shares in the prior two weeks, suggesting a sustained insider selling campaign rather than a one-off liquidity event.

Key Facts

  • Officer Dennis Mulroy filed Form 144 to sell 22,491 shares valued at ~$1.15 million.
  • The filing also discloses 13 prior sales between May 15 and June 4, 2026, totaling ~160,422 shares for ~$8.7 million.
  • The proposed sale is attributed to a stock option exercise, but the aggregate selling pattern is substantial.
  • Market cap is ~$1.5B, so the total disclosed sales (~$9.9M) represent ~0.66% of market cap.
  • No other insider activity reported in the last 30 days per market data snapshot.

Financial Impact

Total disclosed insider sales of ~$9.9 million over the past three weeks, with the latest 144 adding ~$1.15 million.

insider selling volumedilution from option exercise

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed, but the pattern of recent completed sales is confirmed.
  • The selling could be for personal diversification or tax planning, not necessarily a reflection of company outlook.
  • High analyst consensus may already be priced in, and insider selling could precede negative news.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005723
Document: 0001950047-26-005723-index.html0001950047-26-005723
Document: 0001950047-26-005723.txt0001950047-26-005723

Track record

28 reports on ANAB

Performance horizon

10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026